← Evidence map

ArticleMovement disorders clinical practice2026

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease.

Mario Hero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42563427